Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: CYCLOSET

« Back to Dashboard

Summary for Tradename: CYCLOSET

Patents:8
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: CYCLOSET

Ingredient-typeErgolines
Drug ClassErgot Derivative

Clinical Trials for: CYCLOSET

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects
Status: Recruiting Condition: Type 2 Diabetes

Vaginal Bromocriptine for Treatment of Adenomyosis
Status: Recruiting Condition: Adenomyosis

Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
Status: Completed Condition: Type 2 Diabetes Mellitus

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
Status: Recruiting Condition: Parkinson's Disease

Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
Status: Recruiting Condition: Peripartum Cardiomyopathy

Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study
Status: Not yet recruiting Condition: PCOS; Insulin Resistance

QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes
Status: Completed Condition: Diabetes Mellitus, Type 2

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg
Status: Completed Condition: Healthy

Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets
Status: Completed Condition: Healthy

Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment
Status: Terminated Condition: Graves Ophthalmopathy

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866May 5, 2009RXYes5,716,957<disabled><disabled>
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866May 5, 2009RXYes8,137,994<disabled><disabled>
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866May 5, 2009RXYes8,137,993<disabled><disabled>
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866May 5, 2009RXYes7,888,310<disabled><disabled>
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866May 5, 2009RXYes8,137,992<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc